medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 5

<< Back Next >>

Ann Hepatol 2012; 11 (5)

Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis

Ergunay K, Balaban Y, Cosgun E, Alp A, Simsek H, Sener B, Tatar G, Hascelik G

Language: English
References: 21
Page: 672-678
PDF size: 109.17 Kb.


ABSTRACT

Objective. To identify changes in hepatitis B epidemiology after the implementation of the nationwide vaccination program in Turkey, hepatitis B virus (HBV) and related tests performed over a period of 11 years (2000-2010) at a reference centre were retrospectively overviewed and statistically analysed for trends. Results. Assay results for Hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), Anti-HBs, Anti-HBe, Anti-HBc immunoglobulins and HBV DNA as well as aspartate aminotransferase (AST), alanine aminotransferase (ALT), gama-glutamyl transpeptidase (GGT) and alkaline phosphatase (AP) levels, obtained via standardized commercial assays were included in the analysis. Overall, a stable anti-HBs incidence (43.6%) and male predominance in infected individuals were noted. Total Anti-HBc was detected in 43.3% of the Anti-HBs reactive population, demonstrating that the immunity against HBV has still been acquired through virus exposure. An intermediate HBsAg seroprevalence of 6.0% was observed with a significant decrease from 12.3% to 5.0% from 2000 to 2010. Anti-HBe positive infections were more frequent than those with HBe antigenemia (77.1% vs. 18.5%) with a notable increase from 2000 to 2003. HBV DNA was detected in 23.6-25.6% with serological markers of viral replication and was more prevalent in HBeAg positive individuals in parallel with AST, ALT and GGT levels. Evidence for horizontal transfer as the major transmission route was revealed with a reduction of childhood HBV infections, attributable to the ongoing vaccination efforts.


REFERENCES

  1. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.

  2. Carey WD. The prevalence and natural history of hepatitis B in the 21st century. Clev Clin J Med 2009; 76(Suppl. 3): 2-5.

  3. Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004; 8: 255-66.

  4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-25.

  5. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996; 38(Suppl. 2): 2-4.

  6. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18: S20-S22.

  7. Mistik R, Balik I. Epidemiology of viral hepatitis in Turkey: a meta-analysis. In: Kilicturgay K (ed.). Viral hepatitis 98. 1st. Ed. Ankara: Viral Hepatitle Savasim Dernegi; 1998, p. 10-39.

  8. Emekdas G, Cavuslu S, Oncul O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21: 299-305.

  9. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill 2008; 13:pii=18880.

  10. Bozdayi G, Turkyilmaz AR, Idilman R, et al. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 2005; 76: 476-81.

  11. Sayiner AA, Ozcan A, Sengonul A. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus. J Med Virol 2008; 80: 405-10.

  12. Serin MS, Akkiz H, Abayli B, Oksuz M, Aslan G, Emekdas G. Genotyping of hepatitis B virus isolated from chronic hepatitis B patients in the south of Turkey by DNA cycle-sequencing method. Diagn Microbiol Infect Dis 2005; 53: 57-60.

  13. Sertoz RY, Erensoy S, Pas S, Ozacar T, Niesters H. Restriction fragment length polymorphism analysis and direct sequencing for determination of HBV genotypes in a Turkish population. New Microbiol 2008; 31: 189-94.

  14. Protection against Viral Hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1990; 39(RR-2): 1-26.

  15. Koff RS. Vaccination and viral hepatitis-current status and future prospects. Aliment Pharmacol Ther 2007; 26: 1285-92.

  16. Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol 2010; 25: 19-25.

  17. Turkish Statistics Institute. Available from: http://www.turkstat.gov.tr/Start.do

  18. Rosenberg D. Trend analysis and interpretation. Available from: http://mchb.hrsa.gov/mchirc/_pubs/trend_analysis.pdf

  19. Freeman E. Model Map: An R package for modeling and map production using random forest and stochastic gradient boosting. Available from: http://CRAN.Rproject.org/

  20. Degertekin H, Gunes G. Horizontal transmission of hepatitis B virus in Turkey. Public Health 2008; 122: 1315-7.

  21. Degertekin H, Tuzcu A, Yalcin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000; 114: 411-2.




2020     |     www.medigraphic.com